At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II/III Double Blinded, Randomized, Controlled, Non-inferiority Trial to Evaluate the Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Subjects Aged 18-49 Years
In Brief
A Phase 3 clinical trial evaluating GPO Tri Fluvac vaccine and Licensed influenza vaccine for Influenza. Completed, enrolled 945 participants across 2 sites.
Detailed Summary
The study is aim to evaluate the immunogenicity and safety with two groups of participants who will received a seasonal trivalent split, inactivated influenza vaccine (A/H1N1; A/H3N2 and B) or an active comparator (licensed influenza vaccine
Study Details
Timeline
Interventions
The vaccine will be administered via the intramuscular route; the preferred injection site will be the deltoid of the non-dominant arm.
The comparator licensed influenza vaccine will be administered via the intramuscular route; the preferred injection site will be the deltoid of the non-dominant arm.